13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000919574-25-001263
Total Value
$1.28B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEW | MNST | 8,295,690 | $436.0M | 34.06% |
| 2 | AXON ENTERPRISE INC | AXON | 722,421 | $429.3M | 33.54% |
| 3 | STAAR SURGICAL CO | STAA | 10,848,631 | $263.5M | 20.59% |
| 4 | ISHARES TR | 464287655 | 519,920 | $114.9M | 8.98% |
| 5 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 41,666,255 | $20.9M | 1.64% |
| 6 | ONCOCYTE CORP | IMDX | 6,244,405 | $14.9M | 1.16% |
| 7 | SERINA THERAPEUTICS INC | SER | 85,219 | $426,947 | 0.03% |